| |
| |
|
| Insider
Information: |
Bancroft Charles A |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
168,937 |
|
|
Indirect Shares
|
300,000 |
|
|
| Direct
Value |
$6,330,844 |
|
|
|
Indirect Value
|
$12,525,000 |
|
|
| Total
Shares |
468,937 |
|
|
| Total
Value |
$18,855,844 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, Head of Integration |
2020-03-10 |
137,534 |
2020-03-10 |
300,000 |
Premium* |
|
|
Colgate Palmolive Co |
CL |
Director |
2018-05-14 |
5,455 |
2017-05-15 |
0 |
Premium* |
|
|
Kodiak Sciences Inc. |
KOD |
Director |
2020-04-02 |
25,948 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• • – |
2012-12-17 |
4 |
S |
$32.77 |
$1,403,998 |
D/D |
(42,844) |
71,076 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• • – |
2013-05-28 |
4 |
S |
$48.68 |
$1,217,000 |
D/D |
(25,000) |
94,015 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2014-02-14 |
4 |
S |
$54.35 |
$2,878,285 |
D/D |
(52,963) |
77,303 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2014-07-29 |
4 |
S |
$51.06 |
$3,452,532 |
D/D |
(67,621) |
96,564 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2016-05-20 |
4 |
S |
$70.79 |
$2,137,838 |
D/D |
(30,201) |
184,694 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Acting CFO |
• – – |
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,383 |
24,808 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Acting CFO |
• – – |
2010-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,486 |
24,245 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Acting CFO |
• – – |
2010-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,052 |
25,393 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Acting CFO |
• – – |
2010-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,412 |
26,059 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Acting CFO |
• – – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,636 |
43,100 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Financial Officer |
• – – |
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,657 |
42,708 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Financial Officer |
• – – |
2011-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,487 |
43,270 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Financial Officer |
• – – |
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,052 |
44,417 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Financial Officer |
• – – |
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,412 |
45,083 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,747 |
54,316 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,658 |
58,111 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,487 |
59,695 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,052 |
60,842 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,325 |
71,421 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• • – |
2012-12-17 |
4 |
OE |
$23.14 |
$1,191,115 |
D/D |
47,125 |
113,920 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• • – |
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,487 |
73,563 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• • – |
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
69,542 |
142,348 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2014-02-14 |
4 |
OE |
$22.73 |
$870,038 |
D/D |
36,251 |
130,266 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2014-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
121,014 |
199,850 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
• – – |
2014-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,323 |
159,626 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
